The heat-shock response is an evolutionarily conserved cellular defense mechanism against environmental stresses, characterized by the rapid synthesis of heat-shock proteins (HSPs). HSP70, a highly inducible molecular chaperone, assists in refolding or clearance of damaged proteins, thereby having a central role in maintaining intracellular homeostasis and thermotolerance. To date, induction of HSP70 expression has been described extensively at the transcriptional level. However, post-translational regulation of HSP70, such as protein stability, is only partially understood. In this study, we investigated the role of OLA1 (Obg-like ATPase 1), a previously uncharacterized cytosolic ATPase, in regulating the turnover of HSP70. Downregulation of OLA1 in mammalian cells by either RNAi or targeted gene disruption results in reduced steady-state levels of HSP70, impaired HSP70 induction by heat, and functionally, increased cellular sensitivity to heat shock. Conversely, overexpression of OLA1 correlates with elevated HSP70 protein levels and improved thermal resistance. Protein-protein interaction assays demonstrated that binding of OLA1 to the HSP70 carboxyl terminus variable domain hinders the recruitment of CHIP (C-terminus of Hsp70-binding protein), an E3 ubiquitin ligase for HSP70, and thus prevents HSP70 from the CHIPmediated ubiquitination. These findings suggest a novel molecular mechanism by which OLA1 stabilizes HSP70, leading to upregulation of HSP70 as well as increased survival during heat shock.
The heat-shock response is an evolutionarily conserved cellular defense mechanism against environmental stresses, characterized by the rapid synthesis of heat-shock proteins (HSPs). HSP70, a highly inducible molecular chaperone, assists in refolding or clearance of damaged proteins, thereby having a central role in maintaining intracellular homeostasis and thermotolerance. To date, induction of HSP70 expression has been described extensively at the transcriptional level. However, post-translational regulation of HSP70, such as protein stability, is only partially understood. In this study, we investigated the role of OLA1 (Obg-like ATPase 1), a previously uncharacterized cytosolic ATPase, in regulating the turnover of HSP70. Downregulation of OLA1 in mammalian cells by either RNAi or targeted gene disruption results in reduced steady-state levels of HSP70, impaired HSP70 induction by heat, and functionally, increased cellular sensitivity to heat shock. Conversely, overexpression of OLA1 correlates with elevated HSP70 protein levels and improved thermal resistance. Protein-protein interaction assays demonstrated that binding of OLA1 to the HSP70 carboxyl terminus variable domain hinders the recruitment of CHIP (C-terminus of Hsp70-binding protein), an E3 ubiquitin ligase for HSP70, and thus prevents HSP70 from the CHIPmediated ubiquitination. These findings suggest a novel molecular mechanism by which OLA1 stabilizes HSP70, leading to upregulation of HSP70 as well as increased survival during heat shock. The-heat-shock response is an evolutionarily conserved cellular defense mechanism against environmental challenges, such as heat shock, oxidative stress, heavy metals, and toxins. [1] [2] [3] [4] Following stress exposure, a family of heatshock transcription factors (HSFs) rapidly induces the expression of cytoprotective heat-shock proteins (HSPs) including the HSP70 molecular chaperone. 5 HSP70 catalyzes the proper folding of nascent proteins, and under stressful conditions, refolds the damaged proteins, or targets unrepairable proteins for degradation. 6 HSP70 has critical roles in protein homeostasis and thermotolerance in mammalian cells, [7] [8] [9] and also participates in multiple cellular signaling events and developmental processes. 8, 10 HSP70 has been implicated in several neurodegenerative diseases related to protein misfolding and aggregation, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. [11] [12] [13] [14] Additionally, HSP70 is also found highly expressed in various malignant tumors with its expression positively correlated with tumorigenesis, metastasis, and poor therapeutic outcome in human cancers. [15] [16] [17] Owing to its important basal and stress-response functions, HSP70 expression is tightly controlled within a cell, and both HSP70 loss and gain have been shown to contribute to multiple dysfunctional or pathological processes. 11, 18 Upregulation of HSP70 expression is largely attributed to the binding of HSF1 to the heat-shock element (HSE) located at the promoter region of the heat-shock gene (HSP70A1A). 19 However, various post-transcriptional, translational, and posttranslational mechanisms also contribute to the regulation of HSP70 expression in both steady-state and heat-shock response conditions. 20, 21 C-terminus of Hsp70-binding protein (CHIP), an E3 ligase, is shown to mediate ubiquitindependent degradation of HSP70-bound protein substrates as well as HSP70 itself, 18, 22 representing an important mechanism that shuts down the HSP70 response after the damaged proteins are removed. This finding particularly emphasizes the importance of protein degradation in determining the overall levels of the HSP before, during, and after the heat shock.
In our recent efforts in search of novel cellular factors that modulate protein turnover, HSP70 was found to interact with OLA1 (Obg-like ATPase 1), a newly identified ATPase member of the YchF subfamily GTPases. GTPases are the most abundant class of NTP-binding proteins, 23 and have a crucial role in the regulation of diverse cellular processes such as protein translation, intracellular transport, signal transduction, and growth. 24, 25 YchF proteins are highly conserved from yeast to human, 23, 26 and unlike other GTPases, bind and hydrolyze ATP more efficiently than GTP. 27 However, physiological functions of YchF proteins, especially human OLA1, are poorly understood. The yeast YBR025c/Ola1 is associated with the 26S proteasome, 28, 29 whereas the protozoan TcYchF/Ola1 interacts with the proteasome subunit RPN10, ribosomal subunits, and polysomes, 30 suggesting a function in the regulation of protein translation and degradation. Sun et al. 31 reported that OLA1 is downregulated under DNA damage stress, such as etoposide, adriamycin, UV, and ionizing radiation. Recently, our group demonstrated that OLA1 functions as a negative regulator in the antioxidant response by transcription-independent mechanisms. 32, 33 Therefore, it is plausible to reason that OLA1 may function in the regulation of multiple stress responses and, particularly, the classical physical stresses such as heat shock. In the present study, we demonstrate that OLA1 protects cells from heat shock by interfering with the binding and function of the E3 ligase CHIP to HSP70, leading to stabilization of HSP70. Our findings pinpoint to a novel post-translational mechanism by which HSP70 is upregulated due to reduced degradation and increased stability.
Results
OLA1 protects cells from heat shock-induced cell death. To assess the potential involvement of OLA1 in control of the heat-shock response, Ola1-knockout ( À / À ) and wild-type ( þ / þ ) mouse embryonic fibroblast cells (MEFs) were treated with heat shock at either 42 or 451C, and their survival examined following a 6-h recovery period. Compared with Ola1 þ / þ MEFs, Ola1 À / À cells were more sensitive to heat shock at both temperatures as evidenced by morphological changes (Figure 1a ) and significantly decreased cell viability (Figure 1b) . To examine if this phenotype is cell type or species dependent, we generated shRNA-mediated OLA1 knockdown cells derived from human breast cancer cell line MDA-MB-231. Cells stably transfected with OLA1 shRNA exhibited diminished OLA1 expression and were significantly more sensitive to heat shock compared with control cells transfected with nontargeting shRNA (Supplementary Figures S1a-c ). Further, we tested whether overexpression of OLA1 could protect cells from heat shock. Human embryonic kidney (HEK) 293T cells transiently transfected with a YFP-OLA1 fusion construct exhibited significantly increased survival in response to heat shock (Figures 1d and e) compared with control cells expressing the YFP construct. These results suggest that OLA1 may function to protect cells from heat shock-induced cell death.
Since the above observations were made after a period of heat-shock recovery, reflecting both acute stress response and chronic recovery, we sought to further examine the dynamic course of an acute phase of heat-shock response in OLA1-deficient and overexpressing cells. In contrast to Ola1 þ / þ MEFs, which were still viable after a 3-h acute heat shock, cell death was observed in Ola1 À / À MEFs as early as 60 min following the heat shock (Figures 2a and c) . Similarly, cell death induction by heat shock during the acute phase was significantly higher in MDA-MB-231 cells with stable knockdown of OLA1 compared with control cells (Figures 2b and d) . Conversely, overexpression of OLA1 in HEK-293T cells decreased cell death induction from acute heat shock (Supplementary Figures S2a  and b) . Taken together, our findings suggest that OLA1 protects cells from heat shock in both the acute and chronic phases of stress response, and that this cell survivalpromoting function of OLA1 is not limited to a specific type of cells.
OLA1 deficiency affects basal and heat shock-inducible HSP70. We investigated if the observed loss of thermal resistance in OLA1-deficient cells was due to insufficient HSPs or impaired induction of their expression after heat shock. We sought to assess the levels of HSP70, a major HSP, in Ola1-knockout MEFs. HSP70 protein levels were significantly lower in Ola1 À / À MEFs compared with Ola1 þ / þ MEFs (Figure 3a) . To further confirm these findings, we examined HSP70 levels in human cell lines with RNA interference-mediated knockdown of OLA1 expression. Stable OLA1-knockdown MDA-MB-231 cells exhibited decreased basal HSP70 levels compared with their control counterparts (Figure 3b) . Moreover, the role of OLA1 in HSP70 expression was verified in transient transfection experiments. Transient overexpression of OLA1 in either HEK-293T or MDA-MB-231 cells resulted in increased HSP70 protein expression, whereas transient knockdown of OLA1 in these cells led to decreased HSP70 levels ( Supplementary Figures S3a-d) . It is worthwhile to note that basal levels of other HSPs, including HSP110, HSP90, and HSP27, were not affected by the knockdown of OLA1 in either HEK-293T or MDA-MB-231 cells ( Supplementary  Figures S3e and f) . To test the inducibility of HSP70 in OLA1-deficient cells, a non-lethal heat shock was applied and the cells were allowed to recover for 6 h. HSP70 protein levels were significantly lower in Ola1 À / À MEFs relative to Ola1 þ / þ MEFs (Figure 3c ), as well as in MDA-MB-231 cells with stable OLA1 knockdown relative to their control counterparts (Figure 3d ). These results demonstrate that OLA1 positively regulates both the steady-state and heat shock-inducible levels of HSP70. Figures S4c and d ). In addition, knockout or knockdown of OLA1 did not have a significant effect on the induction of HSP70 mRNA following heat shock, as we noted similar increase rates in the mRNA levels among all isogenic cell line pairs tested (Supplementary Figures S4e and f) . Furthermore, using a luciferase reporter system with an innate human HSP70 promoter, we found that OLA1 deficiency did not significantly alter the heat-induced luciferase activities (Supplementary Figure S5) . These findings suggest that OLA1-mediated changes in the expression of HSP70 are unlikely caused by OLA1's action at the transcriptional level. OLA1 in heat-shock response R-F Mao et al OLA1 binds with HSP70. The discordant changes in the protein and transcript levels of HSP70 prompted us to further explore the mechanism by which OLA1 increases HSP70 protein expression, using protein-protein interaction assays to determine whether OLA1 binds to HSP70. Figure 4f ). On the other hand, immunofluorescence staining followed by confocal microscopy analysis demonstrated that OLA1 was colocalized with HSP70 in the cytoplasm in both HEK-293T and HeLa cells (Figures 4g and h) . In an effort to screen for protein interaction partners of OLA1, we performed immunoprecipitation/mass spectrometry analysis of HEK-293T cells that were transfected with a Flag-OLA1-expressing construct and immunoprecipitated with anti-FLAG antibody, and found that HSP70 was among the OLA1-interacting proteins. These results strongly suggest that OLA1 directly interacts with HSP70 under physiological conditions. (Figure 5c ). However, when an unrelated construct (containing HA-USP4) was co-transfected, the difference in expression levels of this reference protein in these two types of cells was insignificant (Figure 5c ). These results further support the hypothesis that OLA1 stabilizes HSP70.
OLA1 binds with HSP70 C-terminal variable domain. It was recently reported that HSP70 stability is controlled by the ubiquitin-proteasome system (UPS). 22 CHIP, an E3 ligase of HSP70, has been shown to ubiquitinate HSP70 and promote HSP70 degradation under both steady-state and heat-shock response conditions. 18, 22 Since we found that OLA1 modulates levels of basal and heat-induced HSP70, likely through binding to HSP70 and affecting its stability, we reasoned that OLA1 and CHIP might compete for binding with HSP70. It is known that CHIP binds to the C-terminus of HSP70. 34, 35 To map the OLA1 binding domain on HSP70 protein, plasmid constructs containing the full-length and truncated mutant HSP70 and the YFP-OLA1 vector were cooverexpressed in HEK-293T cells, and the Myc-tagged HSP70 proteins/fragments were immunoprecipitated with anti-Myc antibodies. Similarly to full-length HSP70, the C-terminal fragment of HSP70 was able to pull down YFP-OLA1 (Figures 6a and b) . However, the N-terminal fragment of HSP70 that only contains the ATPase domain could not pull down OLA1 and neither could a longer fragment containing both the ATPase domain and the peptide binding domain but with the variable domain truncated (Figure 6b ). This suggests that the C-terminal variable domain of HSP70 is the OLA1 binding site. Moreover, endogenous OLA1 was also found to interact with the C-terminal variable domain of HSP70 when Myc-tagged HSP70 proteins/fragments were ectopically expressed in HEK-293T cells (Figures 6a and c) . OLA1 in heat-shock response R-F Mao et al OLA1 blocks CHIP-binding site on HSP70. Since OLA1 binds to the C-terminal of HSP70, the same binding site as for CHIP, we tested whether OLA1 and CHIP compete for binding to HSP70. Immunoprecipitation and immunoblot analysis using HEK-293T cells transfected with increasing concentrations of YFP-OLA1 construct revealed that the binding between CHIP and HSP70 was markedly decreased with increasing concentrations of the fusion protein (Figure 7a ). These results suggest that OLA1 competes with CHIP for HSP70 binding. Conversely, when HSP70 was immunoprecipitated in Ola1 À / À MEFs, more CHIP was coprecipitated than in the control MEFs (Figure 7b ), indicating that more CHIP binds to HSP70 in the absence of OLA1. It is noteworthy that no differences in total CHIP protein level were observed between the Ola1 knockout and wild-type MEFs (Figure 7b) .
We next sought to determine whether HSP70 shuttles between two intracellular complexes, a complex with CHIP and another with OLA1. To probe this question, different antibodies (anti-OLA1, anti-HSP70 and anti-CHIP) were used to immunoprecipitate the HSP70 complexes containing either OLA1 or CHIP, and the components of the complexes were analyzed. We found that OLA1 and CHIP were in the anti-HSP70 immunoprecipitants, OLA1 and HSP70 (but not CHIP) were in the anti-OLA1 immunoprecipitants, and CHIP and HSP70 (but not OLA1) were in the anti-CHIP immunoprecipitants (Figures 7c-e) , suggesting that the HSP70/OLA1 and HSP70/CHIP complexes coexist in cells.
Because OLA1 blocks CHIP binding to HSP70, we reasoned that OLA1 might prevent CHIP from ubiquitinating HSP70. HEK-293T cells were co-transfected with HAubiquitin, Myc-HSP70, and/or YFP-OLA1 plasmids, and after treatment with proteasome inhibitor MG132, the expressed Myc-tagged HSP70 and HA-tagged ubiquitin were immunoprecipitated with anti-Myc and anti-HA antibodies, respectively. The immunoprecipitates were reciprocally immunoblotted with anti-HA and Myc antibodies to monitor the ubiquitination levels of HSP70. As shown in Figure 7f , poly-ubiquitinated HSP70 was markedly decreased in the cells co-transfected with YFP-OLA1 as compared with the cells without YFP-OLA transfection, suggesting that overexpression of OLA1 prevents HSP70 from ubiquitination. Furthermore, when the endogenously expressed HSP70 in Ola1 À / À and the wild-type MEFs was examined with immunoprecipitation, poly-ubiquitinated HSP70 was greatly increased in Ola1-knockout MEFs compared with that in the wild-type MEFs in either the absence or the presence of MG132 (Figure 7g ). These results further support the hypothesis that OLA1 not only blocks CHIP binding to HSP70 but also dampens its function in degradation of HSP70, leading to accumulation of intracellular HSP70.
Discussion
In this study, we demonstrated that OLA1 is a positive regulator of the heat-shock response. Knockdown of OLA1, or Whole cell lysates were also analyzed for the presence of HSP70, ubiquitin, and OLA1 using the corresponding antibodies. b-Actin was used as the loading control OLA1 belongs to the TRAFAC class, Obg family, and YchF subfamily of P-loop NTPases, and is highly conserved from bacteria to human, 23, 26, 32 pointing to its essential functions in fundamental cellular processes. Protein structure analyses suggested that OLA1 functions as a regulatory protein that interacts with downstream effector protein(s) and exerts its downstream functions by switching between the ADP-and ATP-bound forms. 27 The human OLA1 protein is a 45-kDa cytosolic protein ubiquitously expressed in most tissues. 33 Interestingly, in an earlier study, we reported that OLA1 suppresses the antioxidant response via non-transcriptional mechanisms. 33 The fact that OLA1 has important roles in both heat-shock and antioxidant responses indicates that OLA1 is an essential factor for intracellular homeostasis. All currently known heat-shock response modulators are either factors that act on the HSF1/HSE pathway, or that function as molecular chaperones or co-chaperones. 5, 19 Our findings suggest that OLA1 may represent a novel type of heat-shock regulator that modulates HSP70's protein stability. Since we have found that OLA1 co-immunoprecipitates with HSP70 but is absent in the HSP70/CHIP complex (Figures 7c-e) , further studies are warranted to determine whether OLA1 itself is a molecular chaperone or a specific co-chaperone for HSP70.
In this study, we also demonstrated a unique mechanism by which OLA1 upregulates HSP70 to maintain its physiological levels. OLA1 deficiency has no effect on the activity of HSF1 (Supplementary Figure S5) , nor on the transcription of HSP70 mRNA at either basal conditions or under heat shock (Supplementary Figure S4) . On the other hand, the half-life of HSP70 was significantly shortened in cells with knockdown or knockout of OLA1 (Figures 5a and b) and HSP70 protein was more stable in cells with normal OLA1 levels compared with OLA1-deficient cells (Figure 5c ). Therefore, we reasoned that OLA1 might instead affect protein stability. CHIP is an E3 ligase that post-translationally regulates HSP70. 18, 22, 34, 35 It is proposed that HSP70 acts as an adapter for CHIP to ubiquitinate chaperone clients. 18, 36 Because OLA1 blocks CHIP binding to HSP70 (Figures 7a and b) , OLA1 may act on CHIP ubiquitinating chaperone clients by disrupting the binding of the adapter (HSP70) and E3 ligase (CHIP). It will be necessary to study the fate of the HSP70 client proteins in the presence and absence of OLA1 in future studies. Nevertheless, our data have shown that OLA1 competes with CHIP for binding to HSP70 (Figures 7a and b) and levels of HSP70 poly-ubiquitination are inversely correlated with the OLA1 expression (Figures 7f and g ). Thus, we present a model for how OLA1 and CHIP cooperatively regulate intracellular HSP70 levels ( Figure 8 ). As has been previously described, CHIP binds to HSP70 and brings ubiquitin chains to HSP70, leading to subsequent degradation through the ubiquitin/proteasome pathway. However, based on the present study, a new cellular factor, OLA1, is able to compete with CHIP for binding with the HSP70 C-terminal variable domain, causing CHIP to disassociate from HSP70, and thus attenuating HSP70 ubiquitination and degradation.
Our novel findings on increased stability of HSP70 caused by OLA1 may be highly relevant to the molecular pathogenesis of various diseases. HSP70 has been implicated in the molecular pathogenesis of several neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, [11] [12] [13] [14] a group of diseases characterized by the progressive loss of structure or function of neurons. Along with the degeneration of neurons, one of the morphological features associated with many of these diseases is the presence of insoluble protein aggregates. Due to the fact that high expression of HSP70 protects neurons against cellular toxicity, [11] [12] [13] [14] it is plausible that OLA1 might also protect neurons and thus prevent neurodegenerative diseases by enhancing HSP70 levels and function.
Recently, it has been reported that OLA1 was overexpressed in multiple human malignancies, and our own studies also showed that knockdown of OLA1 expression inhibits the motility and invasion of breast cancer cells. 31, 32 Given the important roles of OLA1 in stress responses, it is reasonable to suggest that OLA1 may represent a potential therapeutic target for cancer. One of the hallmarks of cancer cells is the acquired or de novo resistance to diverse stresses such as hypoxia and heat shock. 37 It is now well established that both HSP70 and HSP90 are upregulated in various human malignancies, and are often associated with poor prognosis and increased resistance to chemotherapies and radiotherapies. More importantly, recent studies have demonstrated that a chemical inhibitor of HSP70 exerts prominent tumor-selective cytotoxic effects. 38, 39 Since we have found that knockdown of OLA1 sensitize cancer cells to heat shock in vitro (Figure 2b; Supplementary Figure S1 ), it is plausible to hypothesize that targeting OLA1 could compromise the thermotolerance of a growing tumor in vivo, sensitizing the tumors to thermal ablation or other therapies.
In summary, we have unraveled a new mechanism by which HSP70 is regulated at the protein turnover level. We found that a cytosolic ATPase, OLA1, protects cells from heat shock-induced cell death, at least in part, by binding to the Figure 8 A model of how OLA1 stabilizes HSP70 and protects it from proteasome-mediated degradation. As has been illustrated in previous studies, the E3 ligase, CHIP, binds to HSP70 and brings ubiquitin chain to HSP70. Polyubiquitinated HSP70 is then recognized by proteasome for degradation. In the present study, we demonstrate that OLA1 competes with CHIP in binding to the C-terminal variable domain of HSP70. Once OLA1 binds to HSP70, CHIP loses its access to HSP70 and fails to serve as an E3 ligase to mediate the ubiquitination and degradation of HSP70 40 This specific mouse line was generated from embryonic stem (ES) cells carrying a retroviral vector insertion (OmniBank VICTR48, Lexicon Pharmaceuticals, The Woodlands, TX, USA) at the fifth coding exon of the Ola1 gene. The mutant mice were bred in the 129sv/C57BL6 genetic background. Phenotypic characterization of these mutant mice will be published elsewhere. MEFs were derived from 12.5 day embryos according to standard procedures. 41 Immortalized Ola1 ( þ / þ ) and Ola1 ( À / À ) MEF lines were established by repetitive subculturing of the primary MEFs for 430 passages.
Expression constructs and short-hairpin RNA constructs. The cDNA fragments encoding full-length human HSP70 and truncated HSP70 proteins including aa1-441, aa1-508, and aa442-641 were constructed into the mammalian expression vector pcDNA3.1 (Invitrogen, Grand Island, NY, USA) with a C-terminal Myc tag. Full-length human OLA1 cDNA (NM_013341.3) was cloned into either the pCMV-Tag1 vector (Stratagene, Santa Clara, CA, USA) with an N-terminal FLAG tag, or the pdEYFP-N1gen plasmid with a C-terminal YFP tag as previously described. 33 The pcDNA3.1-HA-CHIP and HA/Flag-CHIP constructs were kindly provided by Dr. Junn Yanagisawa in University of Tsukuba, Ibaraki, Japan. 42 The pcDNA3.1-HA-USP4 and HA-ubiquitin constructs were kindly provided by Dr. Jianhua Yang in Baylor College of Medicine, Houston, USA. 43 For generation of the HSP70 promoter-dependent luciferase reporter constructs (PGL4-hsp70-luc), a 426-bp human Hsp70 promoter sequence 44 was inserted into the HindIII/XhoI sites of the PGL4.18 [lup2P/Neo] vector (Promega, Madison, WI, USA). The CMV promoter-dependent Renilla luciferase reporter plasmid was purchased from Promega. Sh-RNA plasmids used for targeted silencing of OLA1 (sh-OLA1) and the control non-targeting plasmid (sh-control) were made by inserting the following short-hairpin sequences into the pLVTHM vector (Addgene: #12247): 5 0 -CCGGGAGGAAATGATTGGGCCCATTCTCGAGAATGGGCCCAAT CATTTCCTCTTTTTTG-3 0 for sh-OLA1 and 5 0 -CCGGCAACAAGATGAAGAG CACCAACTCGAGTTGGTGCTCTTCATCTTGTTGTTTTTG-3 0 for sh-control. All expression vectors were confirmed by sequencing and purified by a plasmid preparation kit (Macherey Nagel, MN, Bethlehem, PA, USA).
For transfection of the DNA vectors, transfection reagents FuGen 6 (Roche, Florence, SC, USA) or Lipofectamine 2000 (Invitrogen) were used according to manufacturer's instructions. Immunoprecipitation, western blot, and mass spectrometry. Cells were washed with ice-cold PBS (pH 7.4) and then lysed in the lysis buffer (Cell Signaling Technology) containing 25 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% NP-40, 5% glycerol supplemented with complete protease inhibitor cocktail (Thermo Scientific) on ice for 30 min. The lysates were centrifuged for 15 min at 41C. Proteins were immunoprecipitated with the indicated antibodies for 3 h. Protein A/G agarose (Santa Cruz Biotechnology) was then incubated with immunocomplexes overnight and washed six times with ice-cold lysis buffer. For western blot analysis, the cell lysate (50 mg) or immunoprecipitates was heated at 1001C for 10 min in sample loading buffer (Thermo Scientific) and separated by SDS-PAGE (Thermo Scientific, Pierce, Hudson, NH, USA). Proteins were transferred onto polyvinylidene difluoride (PVDF, Bio-Rad, Hercules, CA, USA). The membranes were blocked with 5% non-fat milk for 1 h, probed with primary antibodies at 41C overnight and incubated with secondary antibody (GE Healthcare). Immunoreactive bands were visualized with a chemiluminescence detection system (Thermo Scientific, Pierce). For Mass Spectrometry analysis, HEK-293T cells were transfected with the FLAG-OLA1 vector or the empty vector. The immunoprecipitates were obtained by using anti-Flag antibody from cell lysates. The target binds were excised and the proteins were identified with Mass Spectrometry operated by the Proteomics Core at The Methodist Hospital Research Institute.
Immunofluorescence cell staining. Cells were grown on sterile glass coverslips, fixed in 4% paraformaldehyde for 15 min, permeabilized by 0.2% Triton X-100, and then blocked with 1% BSA for 45 min. Antibodies against OLA1 and HSP70 were incubated overnight at 41C. After washing three times, the cells were probed with fluorescent conjugated secondary antibodies (Invitrogen) for 1 h at room temperature, followed by blue nuclear counterstaining with Hoechst (Invitrogen). Coverslips were mounted and observed with an Olympus Fluoview FV 1000 Laser Scan Confocal Microscope, Olympus America INC, Center Valley, PA, USA. Images were captured using FC-10-ASW 3.0 software, Olympus America INC.
In vitro binding assay. HSP70 protein (Assay Designs) and the recombinant HIS-tagged human OLA1 protein (custom made by Epoch Life Science, Missouri City, TX, USA) were co-incubated at 41C for 3 h in 20 ml buffer (25 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% NP-40, 5% glycerol). The reacted system was amplified using the same buffer, combined with first antibody, and incubated with protein A/G agarose overnight at 41C, then washed six times with the same buffer followed by SDS-PAGE analysis to identify the binding partner. The amount of recombinant HSP70 and OLA1 proteins used in this assay were verified by Coomassie blue (Invitrogen) staining.
Quantitative RT-PCR analysis. Total RNA was extracted using the TRIZOL reagent (Invitrogen). RT-PCR was carried out with the iScript one-step RT-PCR kit with SYBR Green reagent (Bio-Rad) in a Miniopticon thermal cycler (Bio-Rad) following manufacturer's instructions. The mRNA level was analyzed by the relative quantification method based the Ct values obtained from the gene of interest and b-actin (the internal control). The primers were designed using Primer3 software (http://frodo.wi.mit.edu/) as following: human HSP70, sense: OLA1 in heat-shock response R-F Mao et al
